FDA Approves First Postpartum Depression Drug The Food and Drug Administration has approved the use of the drug Zulresso in the treatment of postpartum depression among mothers. This marks the first time a specific medication will be used for treatment. by Alyssa Navarro
Health Ob-Gyns Recommend New Guidelines For Fourth Trimester Postpartum Care For Moms by Athena Yenko
Health Taking An Epidural To Ease Labor Pains May Reduce Likelihood Of Postpartum Depression In Some Women by Saranya Palanisamy
Healthy Living/Wellness Sensitive Parenting May Help Babies Combat The Effects Of Maternal Depression by Rina Marie Doctor
Healthy Living/Wellness Stigma, Financial Barriers Prevent Women From Seeking Postpartum Depression Treatment by Katrina Pascual
Healthy Living/Wellness One In Three Pregnant Women Suffers From Depression And Anxiety by Katherine Derla
Healthy Living/Wellness Marker Found In Human Blood May Help Identify Postpartum Depression Risk by Rina Marie Doctor
Healthy Living/Wellness Postpartum depression and childbirth fears link discovered by Rhodilee Jean Dolor